Evidence map›Paper›PMID 17051348›Full record

ArticleJournal of muscle research and cell motility2006

Arginine supplementation induces myoblast fusion via augmentation of nitric oxide production.

Jodi H D Long, Vitor A Lira, Quinlyn A Soltow, Jenna L Betters, Jeff E Sellman, David S Criswell

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of muscle research and cell motility, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Redox Control of Skeletal Muscle Regeneration.Antioxidants & redox signaling · 2017
    Review
  12. Novel microspheres reduce the formation of deep venous thrombosis and repair the vascular wall in a rat model.Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. L-Arginine as a potential ergogenic aid in healthy subjects.Sports medicine (Auckland, N.Z.) · 2011
    Review
  19. Nitric oxide regulates stretch-induced proliferation in C2C12 myoblasts.Journal of muscle research and cell motility · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jodi H D LongCenter for Exercise Science, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL 32611, USA.
Vitor A Lira
Quinlyn A Soltow
Jenna L Betters
Jeff E Sellman
David S Criswell
University of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The semi-essential amino acid, L-arginine (L-Arg), is the substrate for endogenous synthesis of nitric oxide, a molecule that is involved in myoblast proliferation and fusion. Since L-Arg supply may limit nitric oxide synthase (NOS) activity in endothelial cells, we examined L-Arg supplementation in differentiating mouse myoblasts and tested the hypothesis that L-Arg exerts direct effects on myoblast fusion via augmentation of endogenous nitric oxide production. C(2)C(12) myoblasts in differentiation media received one of the following treatments for 120 h: 1 mM L-Arg, 0.1 mM N-nitro-L-arginine methyl ester (L-NAME), L-Arg + L-NAME, 10 mM L-Lysine, or no supplement (Control). Cultures were fixed and stained with hematoxylin and eosin for microphotometric image analysis of myotube density, nuclear density, and fusion index (% of total nuclei in myotubes). Endogenous production of nitric oxide during the treatment period peaked between 24 and 48 h. L-Arg amplified nitric oxide production between 0 and 24 h and increased myotube density, total nuclei number, and nuclear fusion index. These L-Arg effects were prevented by the NOS inhibitor, L-NAME. Further, L-Lysine, a competitive inhibitor of L-Arg uptake, repressed nitric oxide production and reduced myotube density and fusion index. In summary, L-Arg augments myotube formation and increases nitric oxide production in a process limited by cellular L-Arg uptake.

Indexed as

AnimalsArginineCalcium ChannelsCell DifferentiationCell LineHistocytochemistryMembrane FusionMiceMyoblasts, SkeletalNG-Nitroarginine Methyl EsterNitratesNitric OxideNitritesRNA, MessengerTime FactorsTRPV Cation ChannelsArginineCalcium ChannelsNG-Nitroarginine Methyl EsterNitratesNitric OxideNitritesRNA, MessengerTrpv6 protein, mouseTRPV Cation Channels

Identifiers

PMID17051348
OpenAlexW2053415311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.